Monsanto says it has acquired privately held biotech firm Divergence (St. Louis) for an undisclosed sum. Monsanto says Divergence has "promis- ing tools" in its pipeline to combat nematodes, an increasingly pervasive agricultural pest. "This is an exciting opportunity for Divergence," said Derek Rapp, Divergence's chief executive officer.
展开▼
